SB366791 is a potent and selective antagonist of the TRPV1 receptor, which plays a key role in pain sensation and inflammation. It is widely used in research to study pain pathways, particularly those involving heat, capsaicin, and acid-induced nociception. By blocking TRPV1 activation, SB366791 helps investigate the receptor’s contribution to chronic pain conditions such as neuropathic pain, inflammatory pain, and migraine. It has also been utilized in preclinical studies to evaluate potential analgesic therapies without affecting normal thermal sensitivity, making it a valuable tool for developing targeted pain treatments. Additionally, SB366791 supports studies exploring the role of TRPV1 in non-neuronal tissues, including the bladder, skin, and gastrointestinal tract, where it may influence inflammation and tissue homeostasis.